Puerarin Versus Atorvastatin in Treating Metabolism Syndrome in Patients With Chronic Rheumatic Diseases

• Status: Unknown status
• Trial end date: 2018-12-01
• Target enrollment: 0
• Participant gender: All

Summary

To evaluate the Effect of Puerarin tablets versus statins in treating metabolism syndrome in patients with chronic rheumatic diseases

• Phase: N/A
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Chengdu PLA General Hospital
• Treatments: Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Atorvastatin; Atorvastatin Calcium; Protective Agents; Puerarin

Criteria

Inclusion Criteria:

• patients with a definite diagnose with rheumatic disease

• patients with metabolic Syndrome

• without conflict to the written, informed consent signed prior to the enrollment

• no severe hepatic or renal disorders

• no known carotid artery stenosis

• no coagulation disorders

• no hypertension

Exclusion Criteria:

• being in pregnancy, lactation period or under a pregnancy plan

• being allergic to the test drug

• not compatible for the trial medication

• without full legal capacity